Ankit Lodaya | Senior Director Pharmacovigilance
Beam Therapeutics

Ankit Lodaya, Senior Director Pharmacovigilance, Beam Therapeutics

Accomplished pharmacovigilance professional with approximately 20 years of experience spanning vendor and sponsor roles, with expertise in safety monitoring and operations across clinical trials, regulatory approvals, labeling, commercial use, and registry set-up. I have led teams, served as lead PV scientist for two gene therapy approvals, supported FDA interactions including the first advisory committee for a gene therapy for beta-thalassemia, and led commercial gene therapy programs with ongoing clinical development. My career includes roles at Ironwood Pharmaceuticals, Biogen, bluebird bio, and Beam Therapeutics, and I remain deeply committed to advancing pharmacovigilance and ensuring patient safety.

Appearances:



Day 2: 15th October @ 11:45

Patient safety monitoring for Gene Therapies: Where Traditional PV Models Break Down

last published: 15/Sep/26 07:55 GMT

back to speakers

Get Involved At patient Safety Congress Americas

 

CONNECT WITH US

 

 

To Sponsor

Kieron Carter
kieron.carter@terrapinn.com

+44 20 3481 8981

 

To Speak

Katherine O'Leary
katherine.oleary@terrapinn.com

 

Marketing & Press

Karolina Bzikot
karolina.bzikot@terrapinn.com